ABBV-154 is an anti-TNF antibody-drug conjugate ( ADC ). ABBV-154 is composed of the humanized antibody Adalimumab conjugated with a glucocorticoid receptor modulator. ABBV-154 can be used in studies of rheumatoid arthritis, Crohn's disease and polymyalgia rheumatica.